h_People

Arrow Left About us

Governance

Lygature is a not-for-profit foundation governed by a non-executive Board of Directors, which appoints the Leadership Team and installs a Scientific Advisory Board. In addition, an annual meeting for the stakeholders of Lygature takes place, the Partnerships MeetUp.

At Lygature, we disseminate our knowledge and think about how to further develop public-private partnerships in general, and in our areas of focus. A selection of publications can be found here.

Executive Directors

 

Board of Directors

The Lygature Board of Directors consists of members from various ‘blood groups’ active in public private partnerships. Its current members are:

  • Prof. dr. Peter R. Luijten - Chairperson (Professor of functional medical imaging at UMC Utrecht / Vice Dean at Utrecht Life Sciences)
  • Dr. Hans van Eenennaam (Entrepreneur and co-founder of BioNovion, which became part of Aduro Biotech, currently Chinook Thereapeutics, BOD member of Catalym GmBH and ISD Immunotech ApS)
  • Mr. Ida Haisma (Director Stichting Leiden Bio Science Park)
  • Dr. Mirjam Mol-Arts (Chairperson of the Supervisory Board Organon NV)
  • Drs. Michel Rudolphie MBA (Independent consultant and former director of Dutch Cancer Society)
  • Drs. Hugo R. Hurts (former Executive Director Dutch Medicines Evaluation Board)
  • Prof. dr. Jan Smit (Vice-Chairman of the Radboudumc Executive Board and Dean of the Faculty of Medical Sciences)

Scientific Advisory Board

The tasks of the Scientific Advisory Board are:

  • Advice on the coherence within Lygatures’ project portfolio on an annual basis. Provide feedback and identify chances for cross-fertilization between projects in the various domains. 
  • Provide input on the development of new public-private initiatives from an international perspective, building upon the strengths of the Dutch Life Sciences & Health sector and taking into account the possible connects with international initiatives, such as Horizon2020, the Innovative Medicines Initiative, etc.
  • On an ad hoc basis: review of project proposals that will be submitted by Lygature towards various funders of consortia (e.g. Gates Foundation, GHIT fund, etc). 

The members of the Scientific Advisory Board together span the dimensions in which Lygature is active: scientific discipline (medtech, pharma), geographic scope (national, international), organizational nature (public, private), etc. Current members of the Scientific Advisory Board are:

  • Ton Rijnders, PhD - chairperson (Former General Director Oncode Institute, former Scientific Director Lygature and TI Pharma)
  • Rob Williams, PhD - (Chief Drug Development Scientist at the Centre for Drug Development, Cancer Research UK)
  • Sjaak Deckers, PhD - (Co-founder and CEO of G-Therapeutics BV)
  • Tomas Salmonson PhD - (Partner at Consilium Salmonson & Hemmings, former chair of the Committee for Human Medicinal Products at the European Medicines Agency)

Read more

Lygature Scientific Advisory Board: report on the fourth meeting
Lygature Scientific Advisory Board: report on the third meeting
Lygature Scientific Advisory Board: report on second meeting
Lygature installs Scientific Advisory Board: report on the first meeting

Share this page…